What you should know:
1. The Denmark-based device manufacturer created a two-piece system. There’s the Ambu aScope Duodeno and an accompanying reusable processor unit, the aBox Duodeno.
2. Ambu will now initiate a 500-patient postmarket study at multiple U.S.-based centers, with the goal of making early data available during the 2020-21 fiscal year.
3. The FDA recommended manufacturers and healthcare facilities begin using partial or completely single-use scopes in August 2019. Duodenoscopes have multiple small parts that make the scope difficult to disinfect.
More articles on surgery centers:
Hybrid ASC is up and running with 43 cardiac partners: 6 things to know
Florida ASC closes real-estate sale-leaseback transaction: 4 details
Ohio health system acquires surgery center for $21M
